Titan Pharmaceuticals Stock Market Value
| TTNP Stock | USD 3.63 0.04 1.11% |
| Symbol | Titan |
Titan Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.64) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Titan Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Titan Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Titan Pharmaceuticals.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Titan Pharmaceuticals on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Titan Pharmaceuticals or generate 0.0% return on investment in Titan Pharmaceuticals over 90 days. Titan Pharmaceuticals is related to or competes with Salarius Pharmaceuticals, SAB Biotherapeutics, GeoVax Labs, Senti Biosciences, Cadrenal Therapeutics,, Foghorn Therapeutics, and Quoin Pharmaceuticals. Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases More
Titan Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Titan Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Titan Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.23 | |||
| Information Ratio | 0.035 | |||
| Maximum Drawdown | 32.99 | |||
| Value At Risk | (5.72) | |||
| Potential Upside | 9.85 |
Titan Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Titan Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Titan Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Titan Pharmaceuticals historical prices to predict the future Titan Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0234 | |||
| Jensen Alpha | 0.1616 | |||
| Total Risk Alpha | 0.7809 | |||
| Sortino Ratio | 0.046 | |||
| Treynor Ratio | 0.1226 |
Titan Pharmaceuticals Backtested Returns
Titan Pharmaceuticals appears to be very risky, given 3 months investment horizon. Titan Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0464, which indicates the firm had a 0.0464 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Titan Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Titan Pharmaceuticals' Risk Adjusted Performance of 0.0234, semi deviation of 4.05, and Coefficient Of Variation of 5812.06 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Titan Pharmaceuticals holds a performance score of 3. The entity has a beta of 0.7, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Titan Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Titan Pharmaceuticals is expected to be smaller as well. Please check Titan Pharmaceuticals' semi variance, as well as the relationship between the rate of daily change and relative strength index , to make a quick decision on whether Titan Pharmaceuticals' existing price patterns will revert.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Titan Pharmaceuticals has insignificant reverse predictability. Overlapping area represents the amount of predictability between Titan Pharmaceuticals time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Titan Pharmaceuticals price movement. The serial correlation of -0.2 indicates that over 20.0% of current Titan Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Titan Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Titan Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Titan Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Titan Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Titan Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Titan Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Titan Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Titan Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Titan Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Titan Pharmaceuticals Lagged Returns
When evaluating Titan Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Titan Pharmaceuticals stock have on its future price. Titan Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Titan Pharmaceuticals autocorrelation shows the relationship between Titan Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Titan Pharmaceuticals.
Regressed Prices |
| Timeline |
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.